Background Despite numerous studies supporting the outperformance of ultrathin-strut
bioresorbable polymer sirolimus-eluting stent (Orsiro SES, Biotronik AG), the generalizability …

Purpose: Although the field of interventional cardiology has witnessed extraordinary
progression, the search of an ideal coronary drug-eluting stent is still going on. Tetriflex …

Aims The aim of this study was to assess the real-world clinical performance of a sirolimus-
eluting ultrathin-strut drug-eluting stent (DES)(Orsiro) in a large nationwide cohort of patients …

Objective We evaluated the clinical safety and performance of the ultrathin strut
biodegradable polymer-coated Supraflex Cruz (Sahajanand Medical TechnologiesLtd …

Objective: Although thin-strut drug-eluting stents (DES) with a more flexible design are easily
obtainable, data regarding using ultralong DES (≥ 40 mm) for long coronary lesions are …

Objectives The aim of this study was to determine 1-year safety and efficacy after treatment
with the COMBO and Orsiro stents. Background The COMBO stainless-steel stent has an …

Objectives The aim of this study was to compare late-term clinical outcomes among patients
treated with ultrathin-strut (60-μm) bioresorbable-polymer sirolimus-eluting stents (BP SES) …

Objectives Determine whether an ultrathin biodegradable polymer sirolimus-eluting stent
('Orsiro'—BP-SES) has clinical benefits over second-generation durable polymer drug …

Background The short-term clinical outcomes of first-generation thicker-strut durable
polymer-based drug-eluting stents (DES) have been widely examined. However, there is a …

BACKGROUND: The efficacy and safety of each third-generation drug-eluting stent with
ultrathin struts and advanced polymer technology remain unclear. We investigated the …